30 completed. 30 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 30 | Completed 30 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Indinavir: new trials by email Literature Review of Indinavir trials Research Report on Indinavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma Indinavir in association with Vinblastina +/- Bleomicina - Kaposi's Sarcoma | Phase 2 | Completed | Barbara Ensoli, MD, PhD | 25 | 2008-06-01 | 2016-08-30 |
| The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin indinavir/ritonavir - HIV Infections, Tuberculosis | Phase 1 / Phase 2 | Completed | The HIV Netherlands Australia Thailand Research Collaboration | 20 | 2006-12-01 | 2020-07-17 |
| Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir indinavir - Classical Kaposi's Sarcoma | Phase 2 | Completed | Istituto Superiore di Sanità | 28 | 2003-06-01 | 2008-04-14 |
| Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT), NNRTIs (EFV, NVP), PIs (AMP, IDV, LPV/r, NFV, SQV, RTV) - HIV Infections | Phase 2 / Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 266 | 2002-08-01 | 2021-11-05 |
| A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED) MK0639, indinavir sulfate / Duration of Treatment: 48 Weeks, Comparator: nelfinavir mesylate / Duration of Treatment: 48 Weeks - HIV Infections | Phase 2 | Completed | Merck Sharp & Dohme LLC | 330 | 2001-01-01 | 2017-02-17 |
| A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs Indinavir sulfate, Nelfinavir mesylate, Lamivudine - HIV Infections | Phase 2 | Completed | Glaxo Wellcome | 1999-06-01 | 2005-06-24 | |
| A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir Indinavir sulfate, Abacavir sulfate, Amprenavir - HIV Infections | Phase 2 | Completed | Glaxo Wellcome | 100 | 1999-03-01 | 2005-06-24 |
| Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma indinavir sulfate, nelfinavir mesylate, paclitaxel - Sarcoma | Phase 2 | Completed | Eastern Cooperative Oncology Group | 33 | 1997-12-15 | 2023-06-15 |
| A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas therapeutic autologous dendritic cells, indinavir sulfate, peripheral blood stem cell transplantation - Ewing's Sarcoma, Rhabdomyosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 42 | 1996-12-01 | 2012-06-15 |
| A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood Indinavir sulfate, Lamivudine/Zidovudine, Hydroxyurea - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 399 | 2021-10-29 | |
| A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone Indinavir sulfate, Lamivudine, Stavudine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 200 | 2012-05-21 | |
| Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors Indinavir sulfate, Ritonavir - HIV Infections | Phase 2 | Completed | Merck Sharp & Dohme LLC | 30 | 2005-06-24 | |
| A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir Indinavir sulfate, Amprenavir, Nevirapine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 94 | 2021-11-04 | |
| Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV lopinavir/ritonavir, indinavir sulfate, tenofovir disoproxil fumarate - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 53 | 2021-11-01 | |
| A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir L-756423, Indinavir sulfate - HIV Infections | Phase 2 | Completed | Merck Sharp & Dohme LLC | 30 | 2005-06-24 | |
| Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs Indinavir sulfate, Ritonavir, Nevirapine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 240 | 2021-11-04 | |
| Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 Indinavir sulfate, Abacavir sulfate, Nelfinavir mesylate - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 440 | 2021-10-28 | |
| The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy Indinavir sulfate, Sargramostim - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 108 | 2021-10-29 | |
| A Study of a Combination of Four Drugs in Patients With Recent HIV Infection Indinavir sulfate, Abacavir sulfate, Amprenavir - HIV Infections | Phase 2 | Completed | Glaxo Wellcome | 30 | 2005-06-24 | |
| A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients Indinavir sulfate, Abacavir sulfate, Efavirenz - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 300 | 2021-11-01 |
Showing 20 of 30. Sign in to see all of them.
HIV Infections (26) · Acquired Immunodeficiency Syndrome (3) · Sarcoma, Kaposi (2) · AIDS-Related Complex (1) · AIDS-related Kaposi sarcoma (1) · Mycobacterium avium-intracellulare Infection (1) · Rhabdomyosarcoma (1) · Sarcoma (1) · Sarcoma, Ewing (1) · Tuberculosis (1) · Viremia (1)
National Institute of Allergy and Infectious Diseases (NIAID) (16) · Glaxo Wellcome (4) · Merck Sharp & Dohme LLC (4) · Barbara Ensoli, MD, PhD (1) · Eastern Cooperative Oncology Group (1) · Gilead Sciences (1) · Istituto Superiore di Sanità (1) · National Cancer Institute (NCI) (1) · The HIV Netherlands Australia Thailand Research Collaboration (1)
United States (26) · Puerto Rico (10) · Italy (2) · Tanzania (1) · Thailand (1)
Scott Hammer (3) · Collier A (2) · Ann J. Melvin, MD (1) · Barbara Ensoli, MD, PhD (1) · Benson CA (1) · Chaisson RE (1) · Coombs R (1) · Crystal Mackall, M.D. (1) · Currier JS (1) · Douglas Richman, MD (1) · Elaine Abrams (1) · Ellen Chadwick (1) · Fischl MA (1) · Gail Skowron (1) · Gulick R (1)
PMID 10659875, PMID 11840078, PMID 11980557, PMID 15687448, PMID 17280617, PMID 17726714, PMID 18215978, PMID 18676758, PMID 21239359, PMID 21288774, PMID 21337357, PMID 22250979